Soligenix
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1987-01-01
- Employees
- 15
- Market Cap
- $8.8M
- Website
- http://www.soligenix.com
- Introduction
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing to...
Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2009-06-23
- Last Posted Date
- 2013-12-06
- Lead Sponsor
- Soligenix
- Target Recruit Count
- 140
- Registration Number
- NCT00926575
© Copyright 2024. All Rights Reserved by MedPath